Search
for
Sort by
Research 421–450 of 1000+
- Cutaneous drug reactions
- Differentiation of Adipose Derived Stem Cells by Stimulating with Extracellular Vesicles Secreted from Dermal Papilla Cells Activated with Osteogenic and Adipogenic Inducers
- “Osler’s phenomenon”: misdiagnosing Cushing’s syndrome
- Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial
- Improvement in physicochemical parameters of DPPC liposomes and increase in skin permeation of aciclovir and minoxidil by the addition of cationic polymers
- Evaluation of New Pregnane Derivatives as 5.ALPHA.-Reductase Inhibitor.
- High-performance liquid chromatographic method for the determination of finasteride in human plasma at therapeutic doses
- TSA restores hair follicle-inductive capacity of skin-derived precursors
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Immunosuppressive therapy in autoimmune disease — A review
- Molecular interactions of natural and synthetic steroids in female hamsters’ flank organs
- Isolation and Structural Characterization of Finasteride Degradation Products by Preparative HPLC, HRMS, and NMR
- A Case Report of Kaphaja Granthi w.s.r. to Trichilemmal Cyst
- Multiple Benign Epidermal Inclusion Cysts Clinically Misdiagnosed as Rhinophyma: A Case Report
- Evaluation of the protection of astaxanthin on human hair follicle palilla cells against the aging effects triggered by hydrogen peroxide
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Transnasal cooling: A Pandora’s box of transnasal patho-physiology
- Drugs that affect autonomic functions or the extrapyramidal system
- Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia
- Nonsteroidal inhibitors of human type I steroid 5-.alpha.-reductase
- Anti-androgenic activities of the triterpenoids fraction of Ganoderma lucidum
- Effect of<i>Cuscuta reflexa</i>Roxb on androgen-induced alopecia
- Self-assembled polymeric nanocarriers for the targeted delivery of retinoic acid to the hair follicle
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- What may be the markers of the male equivalent of polycystic ovary syndrome?
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Dermal and Transdermal Drug Delivery through Vesicles and Particles: Preparation and Applications
- Dihydrotestosterone inhibits hair growth in mice by inhibiting insulin-like growth factor-I production in dermal papillae
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- Significant effects of mild endogenous hormonal changes in humans: considerations for low-dose testing.